Some of the major market players operating in the lung stent market are:
Merit Medical Systems, Inc.
Boston Scientific Corporation
Micro-Tech (Nanjing) Co., Ltd.
Hood Laboratories
Cook Group
Taewoong Medical Co Ltd
Novatech SA
Authors:
Mariam Faizullabhoy , Shishanka Wangnoo
Frequently Asked Questions (FAQ) :
Lung stent industry size was more than USD 165 million in 2022 and is estimated to grow at over 11.5% CAGR from 2023 to 2032 driven by the increasing prevalence of COPD and post-tuberculosis stenosis globally.
The tracheal product segment held 69% of the lung stents market revenue share in 2022 and is expected to grow at robust pace through 2032 owing to the decreased risk of surgical complications.
North America lung stent industry generated over USD 72.9 million in 2022 and is anticipated to grow at robust pace through 2032 driven by the rise in hospitalizations for respiratory disorders.
Some of the key lung stent firms include Merit Medical Systems, Inc., Boston Scientific Corporation, Micro-Tech (Nanjing) Co., Ltd., Hood Laboratories, Cook Group, Taewoong Medical Co Ltd, and Novatech SA, among others.